Skip to main navigation Skip to search Skip to main content

Molecular predictors of response and survival in patients with relapsed/refractory acute myeloid leukemia following venetoclax plus hypomethylating agent therapy

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)1865-1869
Number of pages5
JournalHaematologica
Volume110
Issue number8
DOIs
StatePublished - Feb 27 2025

ASJC Scopus subject areas

  • Hematology

Cite this